Recent Securities Litigations

Novavax Inc. Common Stock (NASDAQ: NVAX)

41 Days left to seek lead plaintiff status.

Company Name:Novavax Inc. Common Stock
Stock Symbol:NASDAQ: NVAX
Class Period Start:03/02/2021
Class Period End (inclusive):10/19/2021
Filing Deadline:01/11/2022

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Novavax overstated its manufacturing capabilities and downplayed manufacturing issues that would impact its approval timeline for NVX-CoV2373; (ii) as a result, Novavax was unlikely to meet its anticipated EUA regulatory timelines for NVX-CoV2373; (iii) accordingly, the Company overstated the regulatory and commercial prospects for NVX-CoV2373; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Novavax Inc. Common Stock (NASDAQ: NVAX) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.